VERTEX PHARMACEUTICALS INC earnings per share and revenue

VX1 earnings per share for the last quarter are 3.61 CHF whereas the estimation was 3.65 CHF which accounts for -0.90% surprise. Company revenue for the same period amounts to 2.64 B CHF despite the estimated figure of 2.53 B CHF. Estimated earnings per share for the next quarter are 3.83 CHF, and revenue is expected to reach 2.57 B CHF. Also watch annual changes over time to get a bigger picture of VX1 earnings per share and revenue dynamics.